According to The Times of India, the Competition Commission of India (CCI) has pointed at “unreasonably high trade margins” responsible for exorbitant drug prices, highlighting the role of intermediaries in increasing along with need to promote generic medicines with quality assurance.
The CCI has been clamping down on unfair business practices in the healthcare space. The government has also been taking measures to ensure good practices in the sector. The watchdog’s policy note stated that one major factor that contributes to high drug prices in India is the unreasonably high trade margins.
“The high margins are a form of incentive and an indirect marketing tool employed by drug companies,” an official release quoting the policy note stated. Further, the policy note stated that self regulation by trade associations contributes towards high margins as they control the entire drug distribution system in a manner that reduces competition. “Electronic trading of drugs, with appropriate regulatory safeguards, could be another potent instrument for bringing in transparency and spurring price competition among platforms and among retailers, as has been witnessed in other product segments,” it added.
Full Content: The Times of India
Featured News
Redfin Settles $9.2M Commission Inflation Lawsuits
May 7, 2024 by
CPI
DOJ Supports Colorado’s Efforts to Block Kroger-Albertsons Merger
May 7, 2024 by
CPI
Japan Considers Regulation of AI Developers
May 7, 2024 by
CPI
European Commission Extends Decision Deadline for Ita-Lufthansa Merger
May 7, 2024 by
CPI
UK, US and Australia Sanction Senior Leader of LockBit Cybercrime Gang
May 7, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI